Special Populations

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

The FDA did not grant approval for the treatment for major depressive disorder.

The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.

"Systemic racism is insidious and ingrained in our daily experience. Women of color are doubly minoritized."

“She would never hurt her baby...”

From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.

How does schizophrenia differ between men and women, and what does this mean for developing treatment strategies?

"There is an urgency for competent, thoughtful mental health care for women—not only because the differences have been ignored in the past, but because women’s mental health so often affects health and mental health outcomes for their children."

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.

How can BPD traits affect the transition to parenthood?

"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."

Racism is here and happening all around us. One Muslim woman tells her story.

How can you best address and support transgender patients, as well as prevent negative outcomes?

From the FDA traditional approval of Leqembi to an examination of how we can improve mental health care for women of color, here are highlights from the week in Psychiatric Times.

It is essential that clinicians take an active approach in creating a culturally safe space to provide mental health care to WoC.

Nearly 1 in 2 women compare themselves to Barbie.

A psychiatrist mourns as he reflects on the Supreme Court decision....

How can we turn the tide of the fentanyl epidemic?

Interventions that rely solely on change lack balance. This is especially true when working with minoritized individuals who have very real and justified pain stemming from systemic problems.

Racism must be addressed on an ongoing basis.

From obesity and metabolism in first-episode MDD to psychiatrist liability and suicide, here are highlights from the week in Psychiatric Times.

The politicization of gender-affirming care creates a harmful and dangerous reality for transgender youth.

PME affects many women, yet it remains under-recognized in clinical practice and in research.

"Systemic racism and the disparate treatment of minoritized people are major barriers to effective mental health care for women of color."